Cargando…
Effects of an Omega-3 and Vitamin D Supplement on Fatty Acids and Vitamin D Serum Levels in Double-Blinded, Randomized, Controlled Trials in Healthy and Crohn’s Disease Populations
Two trials separately measured the bioavailability and impact on inflammation of a supplement taken daily containing 510 mg Docosahexaenoic acid (DHA), 344 mg Eicosapentaenoic acid (EPA), and 1000 IU of vitamin D (25-hydroxyvitamin D; 25(OH)D), for healthy and Crohn’s disease (CD) populations. Both...
Autores principales: | Brennan Laing, Bobbi, Cavadino, Alana, Ellett, Stephanie, Ferguson, Lynnette R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230517/ https://www.ncbi.nlm.nih.gov/pubmed/32325778 http://dx.doi.org/10.3390/nu12041139 |
Ejemplares similares
-
The Role of Vitamin D Level and Related Single Nucleotide Polymorphisms in Crohn’s Disease
por: Carvalho, Andre Y. O. M., et al.
Publicado: (2013) -
Omega-3 Fatty Acids and Vitamin D in Cardiology
por: Güttler, Norbert, et al.
Publicado: (2012) -
Effects of Vitamin D(3) Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)
por: Chou, Sharon H, et al.
Publicado: (2021) -
Effect of supplementation with vitamin D(2)-enhanced mushrooms on
vitamin D status in healthy adults
por: Stepien, Magdalena, et al.
Publicado: (2013) -
Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial
por: Mazahery, Hajar, et al.
Publicado: (2016)